|
|
| Countries covered: United States Brief Excerpt from Industry Overview Chapter: The US biotechnology industry includes about 1,500 companies with combined annual revenue of more than $90 billion. Major companies include Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), Genzyme, Life Technologies, and Monsanto. Because many drugs are now developed using biotechnology, the biotechnology and pharmaceutical industries overlap considerably. COMPETITIVE LANDSCAPE Demand for biotechnology research in the fields of medicine, agriculture, food, and science is driven by insurers' willingness to pay for new medical treatments, the global need to produce more food for a rapidly expanding population, and scientists' desire to find solutions for complex scientific and medical issues. Funding for biotech research is often provided by venture capital funds hoping to cash in on new products. The profitability of individual companies depends on the discovery and effective marketing of new products. Because the market for potential products is so large, small biotechnology companies can co-exist successfully with large ones if they have expertise in a particular line of research. The industry is capital intensive: average annual revenue per worker is $500,000. Biotech firms face stiff competition from pharmaceutical and other companies seeking to be first with a new product or discovery. PRODUCTS, OPERATIONS & TECHNOLOGY Biotechnology is used to produce drugs, therapies, vaccines, and medical diagnostic tests. It's also used to produce genetically modified (GM) plants and crops; DNA fingerprinting; environmental biotech products that aid in the clean-up of hazardous waste; and industrial biotech applications that help numerous sectors produce... |
More United States Genetic Engineering Reports
The World Market for Biosimilars and the Potential for US Follow-on Biologics by
Kalorama Information
Biosimilars, or generic biologic drugs, are marketed around the world but still restricted in the U.S. This may soon change, and Kalorama Information has ...
Stem Cell - Analysis and Market Forecasts, 2006-2016 by
RRY Publications
Sales of stem cell products in the United States reached $16.4 million in 2006 and are expected to surpass $35 million in 2007, according to ...
Industries in Transition Industry Review by
BCC Research
This publication is designed to keep you ahead of the trends. Whether you are in marketing, corporate planning, or investing, you need to stay abreast ...
The Emerging Bio-IT Market: The Convergence of IT and Biopharmaceutical R&D - In-Silico High Performance Systems, Services, Opportunities and Market by
Takeda Pacific
The combination of the bioscience industry with the information technology (IT) industry is emerging as an exciting industry segment that is being called bio-IT. Bioinformatics ...
Stem Cell and Progenitor Cell Therapy: Current Uses and Future Possibilities by
BCC Research
This report focuses on the use of cells as medical therapy. This includes, for example, the replacement of the blood and immune systems with blood ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Related Markets
Genetic Engineering Reports
- Genetic Engineering
- Stem Cell Markets
- Patent map and technology intelligence report. Micro-organisms/Enzymes; Propagating, Preserving Or Maintaining Micro-organisms; Genetic Engineering; Culture Media
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- Stem Cell Technology: Current Applications and Future Directions
